Literature DB >> 19640168

A common medical error: lung cancer misdiagnosed as sputum negative tuberculosis.

Vikas Kumar Singh1, Subhash Chandra, Sachin Kumar, Ghanshyam Pangtey, Anant Mohan, Randeep Guleria.   

Abstract

OBJECTIVE: To emphasize that delay in diagnosis of lung cancer can be caused by the wrong diagnosis of tuberculosis (TB) in TB endemic countries. This is of major concern as early-diagnosis of lung cancer can increase the chance of tumor resectability and timely chemo-radiotherapy may provide better quality of life.
METHODS: Proven lung cancer patients, who had received anti-tubercular treatment (ATT) since onset of current symptoms, were studied retrospectively during the period of Nov-07 to Nov-08. DATA-SOURCE: Patient interview and medical records.
RESULTS: Total of 14 out of 70 patients received wrong diagnosis of TB and had received ATT (male-12, female-2; mean age 58.07-/+6.81; Non Small Cell Lung Cancer (NSCLC) -12, Small Cell Lung Cancer (SCLC) -2), 12 were smokers with median smoking pack-years of 44(15 to 112). Pre-referral sputum acid fast bacilli (AFB) was done in only 3 out of these 14 patients and sputum AFB was negative in these 3 patients. ATT was started on the basis of chest X-ray finding and clinical symptoms. Mean duration of ATT taken was 4.46-/+3.15 months.
CONCLUSION: Due to high TB prevalence and radiological similarities, a large number of lung cancer patients initially get wrongly treated for TB. Also, clinicians associate lung cancer with high case-fatality and start ATT without detailed investigation. Altogether, this leads to delay in diagnosis and progression of disease.

Entities:  

Mesh:

Year:  2009        PMID: 19640168

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  18 in total

1.  Evaluation of pulmonary nodules in Asian population.

Authors:  Chee K Phua; Wen Y Sim; Kuan Sen Tee; Sennen J W Lew; Albert Y H Lim; Dessmon Y H Tai; Soon Keng Goh; Ai Ching Kor; Alan W K Ng; John Abisheganaden; Akash Verma
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Authors:  Joo Young Lee; Im Ii Na; Seung-Hun Jang; Yong Il Hwang; Du Hwan Choe; Cheol Hyeon Kim; Heejong Baek
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

3.  Presence of key findings in the medical record prior to a documented high-risk diagnosis.

Authors:  Mitchell J Feldman; Edward P Hoffer; G Octo Barnett; Richard J Kim; Kathleen T Famiglietti; Henry Chueh
Journal:  J Am Med Inform Assoc       Date:  2012-03-19       Impact factor: 4.497

4.  Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing.

Authors:  Kumar Prabhash; Suresh H Advani; Ullas Batra; Bivas Biswas; Anuradha Chougule; Mithua Ghosh; Vamshi Krishna Muddu; T P Sahoo; Ashok K Vaid
Journal:  Adv Ther       Date:  2019-03-12       Impact factor: 3.845

5.  Significance of Total Protein, Albumin, Globulin, Serum Effusion Albumin Gradient and LDH in the Differential Diagnosis of Pleural Effusion Secondary to Tuberculosis and Cancer.

Authors:  Sumeru Samanta; Ashish Sharma; Biswajit Das; Ayaz K Mallick; Amit Kumar
Journal:  J Clin Diagn Res       Date:  2016-08-01

6.  Diagnosis, staging and treatment of patients with non-small cell lung cancer for the surgeon.

Authors:  Ayesha S Bryant; Robert J Cerfolio
Journal:  Indian J Surg       Date:  2010-01-13       Impact factor: 0.656

7.  Pulmonary tuberculosis as differential diagnosis of lung cancer.

Authors:  Mlb Bhatt; Surya Kant; Ravi Bhaskar
Journal:  South Asian J Cancer       Date:  2012-07

8.  The effect of empirical and laboratory-confirmed tuberculosis on treatment outcomes.

Authors:  Osman Abdullahi; Ngari Moses; Deche Sanga; Willetts Annie
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

9.  Pulmonary tuberculosis and lung cancer: simultaneous and sequential occurrence.

Authors:  Denise Rossato Silva; Dirceu Felipe Valentini; Alice Mânica Müller; Carlos Podalirio Borges de Almeida; Paulo de Tarso Roth Dalcin
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

10.  Tuberculosis and lung cancer.

Authors:  Somsri Wiwanitkit; Viroj Wiwanitkit
Journal:  South Asian J Cancer       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.